BioMarin
Trade BioMarin 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMRN
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.
BMRN Key Statistics
Stock Snapshot
The current BioMarin(BMRN) stock price is $58.13, with a market capitalization of 11.17B. The stock trades at a price-to-earnings (P/E) ratio of 21.78.
As of 2026-02-08, BioMarin(BMRN) stock has fluctuated between $57.20 and $58.43. The current price stands at $58.13, placing the stock +1.6% above today's low and -0.5% off the high.
The BioMarin(BMRN)'s current trading volume is 1.64M, compared to an average daily volume of 1.75M.
In the last year, BioMarin(BMRN) shares hit a 52-week high of $73.51 and a 52-week low of $50.76.
In the last year, BioMarin(BMRN) shares hit a 52-week high of $73.51 and a 52-week low of $50.76.
BMRN News
Advertisement Setting the scene for BioMarin Pharmaceutical BioMarin Pharmaceutical (BMRN) has been drawing attention after recent share price swings, with a...
Piper Sandler lowered the firm’s price target on BioMarin (BMRN) to $84 from $122 and keeps an Overweight rating on the shares. Following a number of Q4/FY25 pr...
Analyst ratings
78%
of 27 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.